Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Irritable Bowel Syndrome, August 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 54 articles:
HTML format


 

Single Articles

  1. GUAN T, Li T, Cai W, Huang D, et al
    HTR3A and HTR3E gene polymorphisms and diarrhea predominant irritable bowel syndrome risk: evidence from a meta-analysis.
    Oncotarget. 2017 Jul 29. doi: 10.18632/oncotarget.19682.
    Abstract    

    Abstract available

  2. BURCHAKOV DI, Uspenskaya YB
    [Antioxidant, anti-inflammatory and sedative effects of melatonin: results of clinical trials].
    Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117.
    Abstract    

    Abstract available

  3. LAW IKM, Padua DM, Ilopoulos D, Pothoulakis C, et al
    Role of G protein-coupled receptors-microRNA interactions in Gastrointestinal Pathophysiology.
    Am J Physiol Gastrointest Liver Physiol. 2017 Aug 3:ajpgi.00144.2017.
    Abstract    

    Abstract available

  4. JACENIK D, Cygankiewicz AI, Fichna J, Mokrowiecka A, et al
    Estrogen signaling deregulation related with local immune response modulation in irritable bowel syndrome.
    Mol Cell Endocrinol. 2017 Jul 31. pii: S0303-7207(17)30416.
    Abstract    

    Abstract available

  5. ENOKIDO T, Shibuya H, Osamura K, Ohtani M, et al
    Polycarbophil Calcium Lodged in the Bronchus.
    Intern Med. 2017;56:2075-2076.
    Abstract    



  6. ANKERSEN DV, Weimers P, Burisch J
    Whats 'App-ening': the help of new technologies in nutrition in digestive diseases.
    Curr Opin Clin Nutr Metab Care. 2017;20:426-431.
    Abstract    

    Abstract available

  7. BUCKER R, Krug SM, Moos V, Bojarski C, et al
    Campylobacter jejuni impairs sodium transport and epithelial barrier function via cytokine release in human colon.
    Mucosal Immunol. 2017 Aug 2. doi: 10.1038/mi.2017.
    Abstract    

    Abstract available

  8. EL-SALHY M, Gilja OH
    Abnormalities in ileal stem, neurogenin 3, and enteroendocrine cells in patients with irritable bowel syndrome.
    BMC Gastroenterol. 2017;17:90.
    Abstract    

    Abstract available

  9. MASUY I, Van Oudenhove L, Tack J, Biesiekierski JR, et al
    Effect of intragastric FODMAP infusion on upper gastrointestinal motility, gastrointestinal, and psychological symptoms in irritable bowel syndrome vs healthy controls.
    Neurogastroenterol Motil. 2017 Aug 1. doi: 10.1111/nmo.13167.
    Abstract    

    Abstract available

  10. TSIGARIDAS A, Anagnostopoulos AK, Papadopoulou A, Ioakeim S, et al
    Identification of serum proteome signature of irritable bowel syndrome: Potential utility of the tool for early diagnosis and patient's stratification.
    J Proteomics. 2017 Jul 28. pii: S1874-3919(17)30260.
    Abstract    

    Abstract available

  11. BELLONO NW, Bayrer JR, Leitch DB, Castro J, et al
    Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways.
    Cell. 2017;170:185-198.
    Abstract    

    Abstract available

  12. HALMOS EP, Biesiekierski JR, Newnham ED, Burgell RE, et al
    Inaccuracy of patient-reported descriptions of and satisfaction with bowel actions in irritable bowel syndrome.
    Neurogastroenterol Motil. 2017 Aug 10. doi: 10.1111/nmo.13187.
    Abstract    

    Abstract available

  13. DOIRON RC, Kogan BA, Tolls V, Irvine-Bird K, et al
    Childhood bladder and bowel dysfunction predicts irritable bowel syndrome phenotype in adult interstitial cystitis/bladder pain syndrome patients.
    Can Urol Assoc J. 2017;11:255-259.
    Abstract    

    Abstract available

  14. LALOUNI M, Ljotsson B, Bonnert M, Hedman-Lagerlof E, et al
    Internet-Delivered Cognitive Behavioral Therapy for Children With Pain-Related Functional Gastrointestinal Disorders: Feasibility Study.
    JMIR Ment Health. 2017;4:e32.
    Abstract    

    Abstract available

  15. DELGADO-HERRERA L, Banderas B, Ojo O, Kothari R, et al
    Diarrhea-predominant irritable bowel syndrome: creation of an electronic version of a patient-reported outcome instrument by conversion from a pen-and-paper version and evaluation of their equivalence.
    Patient Relat Outcome Meas. 2017;8:83-95.
    Abstract    

    Abstract available

  16. KINSINGER SW
    Cognitive-behavioral therapy for patients with irritable bowel syndrome: current insights.
    Psychol Res Behav Manag. 2017;10:231-237.
    Abstract    

    Abstract available

  17. WEI H, Liu ZJ, Wang K, Zheng W, et al
    [The dietary features of diarrhea predominant irritable bowel syndrome patients with small intestinal bowel overgrowth].
    Zhonghua Nei Ke Za Zhi. 2017;56:567-571.
    Abstract    

    Abstract available

  18. FAN WT, Ding C, Xu NN, Zong S, et al
    Close association between intestinal microbiota and irritable bowel syndrome.
    Eur J Clin Microbiol Infect Dis. 2017 Aug 7. doi: 10.1007/s10096-017-3060.
    Abstract    

    Abstract available

  19. WANG K, Gaitsch H, Poon H, Cox NJ, et al
    Classification of common human diseases derived from shared genetic and environmental determinants.
    Nat Genet. 2017 Aug 7. doi: 10.1038/ng.3931.
    Abstract    

    Abstract available

  20. LIU S, Hagiwara SI, Bhargava A
    Early-life adversity, epigenetics, and visceral hypersensitivity.
    Neurogastroenterol Motil. 2017;29.
    Abstract    

    Abstract available

  21. COOPER TE, Heathcote LC, Clinch J, Gold JI, et al
    Antidepressants for chronic non-cancer pain in children and adolescents.
    Cochrane Database Syst Rev. 2017;8:CD012535.
    Abstract    

    Abstract available

  22. POULSEN CH, Eplov LF, Hjorthoj C, Eliasen M, et al
    Irritable bowel symptoms and the development of common mental disorders and functional somatic syndromes identified in secondary care - a long-term, population-based study.
    Clin Epidemiol. 2017;9:393-402.
    Abstract    

    Abstract available

  23. EJERSKOV C, Krogh K, Ostergaard JR, Fassov JL, et al
    Constipation in adults with neurofibromatosis type 1.
    Orphanet J Rare Dis. 2017;12:139.
    Abstract    

    Abstract available

  24. LI C, Yu S, Li H, Zhou J, et al
    Clinical features and risk factors for irritable bowel syndrome in Migraine patients.
    Pak J Med Sci. 2017;33:720-725.
    Abstract    

    Abstract available


  25. Eluxadoline for IBS-D.
    Drug Ther Bull. 2017;55:90-93.
    Abstract    

    Abstract available

  26. LASHERMES A, Boudieu L, Barbier J, Sion B, et al
    Adherent-Invasive E. coli enhances colonic hypersensitivity and P2X receptors expression during post-infectious period.
    Gut Microbes. 2017 Aug 14:0. doi: 10.1080/19490976.2017.1361091.
    Abstract    

    Abstract available

  27. VORK L, Weerts ZZRM, Mujagic Z, Kruimel JW, et al
    Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study.
    Neurogastroenterol Motil. 2017 Aug 14. doi: 10.1111/nmo.13189.
    Abstract    

    Abstract available

  28. ALLEN AP, Dinan TG, Clarke G, Cryan JF, et al
    A psychology of the human brain-gut-microbiome axis.
    Soc Personal Psychol Compass. 2017;11:e12309.
    Abstract    

    Abstract available

  29. GAWRON AJ, Bielefeldt K
    Risk of Pancreatitis Following Treatment of Irritable Bowel Syndrome with Eluxadoline.
    Clin Gastroenterol Hepatol. 2017 Aug 10. pii: S1542-3565(17)30935.
    Abstract    

    Abstract available

  30. KIM KS, Kim HJ, Lee SH, Cho ST, et al
    Association between Irritable Bowel Syndrome and Overactive Bladder: a Research Survey.
    Urology. 2017 Aug 10. pii: S0090-4295(17)30710.
    Abstract    

    Abstract available

  31. KORZENIK J, Koch AK, Langhorst J
    Complementary and Integrative Gastroenterology.
    Med Clin North Am. 2017;101:943-954.
    Abstract    

    Abstract available

  32. HEIDELBAUGH JJ
    These 3 tools can help you streamline management of IBS.
    J Fam Pract. 2017;66:346-353.
    Abstract    

    Abstract available

  33. GHOSHAL UC, Gwee KA
    Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth: the missing link.
    Nat Rev Gastroenterol Hepatol. 2017;14:435-441.
    Abstract    

    Abstract available

  34. BHATTARAI Y, Schmidt BA, Linden DR, Larson ED, et al
    Human-derived gut microbiota modulates colonic secretion in mice by regulating 5-HT3 receptor expression via acetate production.
    Am J Physiol Gastrointest Liver Physiol. 2017;313:G80-G87.
    Abstract    

    Abstract available

  35. DALZIEL JE, Fraser K, Young W, McKenzie CM, et al
    Gastroparesis and lipid metabolism-associated dysbiosis in Wistar-Kyoto rats.
    Am J Physiol Gastrointest Liver Physiol. 2017;313:G62-G72.
    Abstract    

    Abstract available

  36. DAVYDOV DM, Naliboff B, Shahabi L, Shapiro D, et al
    Asymmetries in reciprocal baroreflex mechanisms and chronic pain severity: Focusing on irritable bowel syndrome.
    Neurogastroenterol Motil. 2017 Aug 22. doi: 10.1111/nmo.13186.
    Abstract    

    Abstract available

  37. LI L, Zhou X, Yu B, Huang H, et al
    Palladium-Catalyzed Dehydrogenative Difunctionalization of Aminoalkenes with Aminals as Oxidants and Electrophiles.
    Org Lett. 2017 Aug 22. doi: 10.1021/acs.orglett.7b02203.
    Abstract    

    Abstract available

  38. BI Z, Zheng Y, Yuan J, Bian Z, et al
    The Efficacy and Potential Mechanisms of Chinese Herbal Medicine on Irritable Bowel Syndrome.
    Curr Pharm Des. 2017 Aug 21. doi: 10.2174/1381612823666170822101606.
    Abstract    

    Abstract available

  39. CHEN L, Ilham SJ, Feng B
    Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article.
    Anesth Pain Med. 2017;7:e42747.
    Abstract    

    Abstract available

  40. RADZIWON CD, Lackner JM
    Cognitive Behavioral Therapy for IBS: How Useful, How Often, and How Does It Work?
    Curr Gastroenterol Rep. 2017;19:49.
    Abstract    

    Abstract available


  41. Correction to: Fuke, Aizawa, Suganuma, Takagi, and Naito, Effect of combined consumption of Lactobacillus brevis KB290 and beta-carotene on minor diarrhoea-predominant irritable bowel syndrome-like symptoms in healthy subjects: a randomised, double-bl
    Int J Food Sci Nutr. 2017 Aug 18:1. doi: 10.1080/09637486.2017.1363996.
    Abstract    



  42. HO V, Brunetti V, Peacock S, Massey TE, et al
    Exposure to meat-derived carcinogens and bulky DNA adduct levels in normal-appearing colon mucosa.
    Mutat Res. 2017;821:5-12.
    Abstract    

    Abstract available

  43. CHOPRA J, Patel N, Basude D, Gil-Zaragozano E, et al
    Abdominal pain-related functional gastrointestinal disorders in children.
    Br J Nurs. 2017;26:624-631.
    Abstract    

    Abstract available

  44. WILKINS T, Sequoia J
    Probiotics for Gastrointestinal Conditions: A Summary of the Evidence.
    Am Fam Physician. 2017;96:170-178.
    Abstract    

    Abstract available

  45. TUCK CJ, Taylor KM, Gibson PR, Barrett JS, et al
    Increasing Symptoms in Irritable Bowel Symptoms With Ingestion of Galacto-Oligosaccharides Are Mitigated by alpha-Galactosidase Treatment.
    Am J Gastroenterol. 2017 Aug 15. doi: 10.1038/ajg.2017.
    Abstract    

    Abstract available

  46. SOGHOMONYAN S, Abdel-Rasoul M, Zuleta-Alarcon A, Grants I, et al
    Clopidogrel IBS Patients Have Higher Incidence of Gastrointestinal Symptoms Influenced by Age and Gender.
    Dig Dis Sci. 2017 Aug 24. doi: 10.1007/s10620-017-4707.
    Abstract    

    Abstract available

  47. TACK J, Corsetti M, Camilleri M, Quigley EM, et al
    Plausibility criteria for putative pathophysiological mechanisms in functional gastrointestinal disorders: a consensus of experts.
    Gut. 2017 Aug 16. pii: gutjnl-2016-312230. doi: 10.1136/gutjnl-2016-312230.
    Abstract    

    Abstract available

  48. ZUCKERMAN MJ, Schmulson MJ, Bashashati M, Jia Y, et al
    Irritable Bowel Syndrome on the US Mexico Border: A Survey in an Indigent Population Using Rome III Criteria.
    J Clin Gastroenterol. 2017 Aug 4. doi: 10.1097/MCG.0000000000000898.
    Abstract    

    Abstract available

  49. QUIGLEY BM, Sova CC, Brenner DM, Keefer LA, et al
    (Can't Get No) Patient Satisfaction: The Predictive Power of Demographic, GI, and Psychological Factors in IBS Patients.
    J Clin Gastroenterol. 2017 Aug 4. doi: 10.1097/MCG.0000000000000906.
    Abstract    

    Abstract available

  50. SU T, Lai S, Lee A, He X, et al
    Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth.
    J Gastroenterol. 2017 Aug 2. doi: 10.1007/s00535-017-1371.
    Abstract    

    Abstract available

  51. NAKAJIMA A, Seki M, Taniguchi S
    Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial.
    J Gastroenterol. 2017 Aug 24. doi: 10.1007/s00535-017-1383.
    Abstract    

    Abstract available

  52. KHAYYATZADEH SS, Kazemi-Bajestani SMR, Mirmousavi SJ, Heshmati M, et al
    Dietary behaviors in relation to prevalence of irritable bowel syndrome in adolescent girls.
    J Gastroenterol Hepatol. 2017 Aug 2. doi: 10.1111/jgh.13908.
    Abstract    

    Abstract available

  53. VARJU P, Farkas N, Hegyi P, Garami A, et al
    Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies.
    PLoS One. 2017;12:e0182942.
    Abstract    

    Abstract available

  54. BUSCAIL C, Sabate JM, Bouchoucha M, Torres MJ, et al
    Association between self-reported vegetarian diet and the irritable bowel syndrome in the French NutriNet cohort.
    PLoS One. 2017;12:e0183039.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;